Medinotec (MDNC) Common Equity (2022 - 2026)

Medinotec's Common Equity history runs 5 years deep, the most recent figure standing at $5.9 million for Q2 2026.

• Quarterly Common Equity rose 33.96% year-over-year to $5.9 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $5.9 million (up 33.96% YoY) and the FY2026 annual result came in at $5.7 million, up 33.73% from the prior year.
• Common Equity was $5.9 million for Q2 2026 at Medinotec, up from $5.7 million in the prior quarter.
• Across five years, Common Equity topped out at $5.9 million in Q2 2026 and bottomed at -$729826.0 in Q3 2022.
• A 5-year average of $2.9 million and a median of $2.6 million in 2023 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2023 — Common Equity surged 17585.75% — and 2024, when it decreased 15.21%.
• Medinotec's Common Equity stood at $11734.0 in 2022, then jumped by 17585.75% to $2.1 million in 2023, then jumped by 36.17% to $2.8 million in 2024, then jumped by 94.64% to $5.5 million in 2025, then grew by 6.4% to $5.9 million in 2026.
• Business Quant data shows MDNC's Common Equity at $5.9 million in Q2 2026, $5.7 million in Q1 2026, and $5.5 million in Q4 2025.